Results 121 to 130 of about 32,129 (220)

Voriconazole and multidrug resistance in Candida albicans

, 2007
In vitro activity of voriconazole against fluconazole-resistant Candida albicans clinical isolates with identified molecular basis of multidrug resistance (MDR) and recombinant Saccharomyces cerevisiae expressing C.
Barchiesi, Francesco, Morschhäuser, Joachim, Wakieć, Roland, Milewski, Sławomir, Borowski, Edward, Prasad, Rajendra   +5 more
core   +2 more sources

Pharmacoeconomics of voriconazole

, 2015
Voriconazole is a second-generation triazole that is a synthesized derivative of fluconazole. It first appeared in the US market in 2002. Voriconazole is available in oral and intravenous dosage forms, and does have excellent bioavailability.
Al-Badriyeh, Daoud
core  

Intravenous voriconazole after toxic oral administration

, 2010
In a male patient with rhinocerebral invasive aspergillosis, prolonged high-dosage oral administration of voriconazole led to hepatotoxicity combined with a severe cutaneous reaction while intravenous administration in the same patient did not.
Van Assen, S., Alffenaar, J.W.C., Kosterink, J.G.W., Van Der Werf, T.S., Kosterink, J.G.W.; id_orcid, Uges, D.R.A., De Monchy, J.G.R.   +6 more
core   +1 more source

Voriconazole is rapidly incorporated.

, 2013
Arabidopsis seedlings were incubated for the indicated periods of time in ATS media supplemented with 25 µM voriconazole and the in situ contents of voriconazole were quantified by HPLC-DAD analysis. The means and standard deviations were calculated from
Wilfried Schwab (52238), Markus Idlhammer (102813), Wilfried Rozhon (102805), Mamoona Khan (102810), Daria Shumilina (102816), Thomas Hoffmann (102821), Brigitte Poppenberger (102826), Sigrid Husar (102806), Theo Lange (102818), Shozo Fujioka (102824), Florian Kalaivanan (102808)   +10 more
core   +1 more source

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

, 2018
Rayo Morfín-Otero,1,2 Martha Alvarado-Ibarra,3 Eduardo Rodriguez-Noriega,1,2 Jesus Resendiz-Sanchez,4 Dipen A Patel,5 Jennifer M Stephens,5 Manuela Di Fusco,6 Carlos F Mendoza,6 Claudie Charbonneau7 1Institute of Infectious and Experimental ...
Stephens JM, Morfín-Otero R, Di Fusco M, Rodriguez-Noriega E, Alvarado-Ibarra M, Resendiz-Sanchez J, Patel DA, Mendoza CF, Charbonneau C   +8 more
core  

Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

, 2018
INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.METHODS: The relationship ...
Cole, David EC, Božović, Andrea, Brandwein, Joseph M, Kumar, Deepali, Saini, Lalit, Wong, Betty YL, Atenafu, Eshetu G, Seki, Jack T   +7 more
core   +1 more source

Voriconazole Induced Bullous Phototoxicity

, 2019
Introduction: Voriconazole, commonly used for invasive aspergillosis treatment, can cause cutaneous adverse effects including photosensitivity. We outline a case of bullous phototoxicity secondary to voriconazole, a condition seldom reported. Case Report:
Pritchett, Ellen N, Luther, Chelsea, Artz, Christina   +2 more
core  

Voriconazole Treatment Schedule.

, 2013
Voriconazole Treatment Schedule.
Joris Veltman (431438), Jordan Dimitrakoff (431442), Adam P. Fagin (147181), Theo S. Plantinga (164719), Emeric F. Bojarski (431436), Mihai G. Netea (105648), Alexander Hoischen (195016), Adam C. Strauss (431437), Victor J. Anciano Granadillo (431440), Stephen A. Allsop (431439), Arsani William (431441)   +10 more
core   +1 more source

Voriconazole-induced periostitis

, 2019
In this case report, a 49-year-old man was diagnosed with influenza-associated invasive aspergillosis. Voriconazole therapy was initiated and adjusted to meet therapeutic range.
Katzenstein, Terese Lea, Justad, Bjarte Aspenes, Helweg-Larsen, Jannik, Jakobsen, Ditte Marie   +3 more
core  

Voriconazole toxicology

, 2015
Treatment with voriconazole can be associated with a number of adverse effects that in some cases may require treatment discontinuation or switching to another agent.
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core